MYRA BIOVARME AS

4848 ARENDAL

Finances

Share Ownership

Return on Equity

3,43 %

Current Ratio

1,16

Debt-to-Equity Ratio

0,58

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 344 000	4 083 000	3 458 000	3 783 000
Net Income	178 000	666 000	703 000	793 000
Total Assets	9 933 000	9 778 000	10 485 000	10 444 000
Total Equity	5 187 000	6 009 000	6 343 000	6 640 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 344 000	4 083 000	3 458 000	3 783 000
Expenditure	3 976 000	3 134 000	2 457 000	2 603 000
Operating Profit	368 000	949 000	1 001 000	1 179 000
Financial Income	0	1 000	0	1 000
Financial Costs	71 000	49 000	73 000	127 000
Financial Balance	−71 000	−48 000	−73 000	−126 000
Earnings Before Tax	297 000	902 000	929 000	1 054 000
Tax	119 000	236 000	226 000	260 000
Net Income	178 000	666 000	703 000	793 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	7 912 000	8 158 000	8 477 000	8 602 000
Total Current Assets	2 020 000	1 619 000	2 008 000	1 843 000
Total Assets	9 933 000	9 778 000	10 485 000	10 444 000
Total Retained Equity	242 000	1 064 000	1 399 000	1 696 000
Total Equity	5 187 000	6 009 000	6 343 000	6 640 000
Total Long-Term Debt	3 000 000	1 660 000	1 734 000	1 922 000
Total Current Debt	1 746 000	2 109 000	2 407 000	1 882 000
Total Equity and Debt	9 933 000	9 778 000	10 485 000	10 444 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	4 257 000	3 999 000	3 388 000	3 735 000
Other Income	87 000	84 000	70 000	47 000
Revenue	4 344 000	4 083 000	3 458 000	3 783 000
Cost of Goods Sold	775 000	753 000	584 000	950 000
Salary Costs	269 000	244 000	218 000	165 000
Depreciation	784 000	736 000	704 000	670 000
Impairment	0	0	0	0
Expenditure	3 976 000	3 134 000	2 457 000	2 603 000
Operating Profit	368 000	949 000	1 001 000	1 179 000
Financial Income	0	1 000	0	1 000
Financial Costs	71 000	49 000	73 000	127 000
Financial Balance	−71 000	−48 000	−73 000	−126 000
Dividends	1 000 000	1 000 000	1 000 000	0
Net Income	178 000	666 000	703 000	793 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	7 298 000	7 452 000	7 679 000	8 315 000
Machinery and Plant Facilities	614 000	706 000	798 000	287 000
Fixtures	0	0	0	0
Total Tangible Assets	7 912 000	8 158 000	8 477 000	8 602 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	7 912 000	8 158 000	8 477 000	8 602 000
Stock	83 000	69 000	111 000	79 000
Total Investments	0	0	0	0
Cash, Bank	1 030 000	673 000	1 283 000	828 000
Total Current Assets	2 020 000	1 619 000	2 008 000	1 843 000
Total Assets	9 933 000	9 778 000	10 485 000	10 444 000
Total Equity	5 187 000	6 009 000	6 343 000	6 640 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	3 000 000	1 660 000	1 734 000	1 922 000
Creditors	514 000	264 000	336 000	210 000
Unpaid Taxes	29 000	151 000	86 000	124 000
Dividends	1 000 000	1 000 000	1 000 000	0
Other Current Debt	84 000	458 000	759 000	1 286 000
Total Current Debt	1 746 000	2 109 000	2 407 000	1 882 000
Total Equity and Debt	9 933 000	9 778 000	10 485 000	10 444 000

Financial indicators	2022	2021	2020	2019
Return on Equity	3,43 %	11,08 %	11,08 %	11,94 %
Debt-to-Equity Ratio	0,58	0,28	0,27	0,29
Operating Profit Margin	8,47 %	23,24 %	28,95 %	31,17 %
Current Ratio	1,16	0,77	0,83	0,98
Quick Ratio	1,21	0,79	0,87	1,02
Equity Ratio	0,52	0,61	0,6	0,64
Gross Profit Margin	82,16 %	81,56 %	83,11 %	74,89 %